Origin Life Sciences Abstract Accepted for Presentation at 2024 Military Health System Research Symposium (MHSRS) Discussing Innovative Technologies and Devices for Treatment of Battlefield Wounds in Prolonged Care to Prevent Infection
June 11, 2024 12:15 ET
|
Origin Life Sciences, Inc.
PRINCETON, N.J., June 11, 2024 (GLOBE NEWSWIRE) -- Origin Life Sciences, Inc., a clinical-stage biotechnology company developing a proprietary patented high-energy plasma device that generates...